Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Medicine, Dermatology, Immunology +17

Guidelines of care for the management of atopic dermatitis

Lawrence F. Eichenfield, Wynnis L. Tom, Timothy G. Berger et al. · Journal of the American Academy of Dermatology · 2014 · 1.2K citations · Full text

Medicine, Dermatology, Immunology +12

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith et al. · British Journal of Dermatology · 2017 · 475 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Atopic dermatitis in the pediatric population

Jonathan I. Silverberg, S. Barbarot, Abhijit Gadkari et al. · Annals of Allergy Asthma & Immunology · 2021 · 445 citations · Full text

Medicine, Dermatology, Pediatrics +10

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi et al. · Journal of the American Academy of Dermatology · 2020 · 389 citations · Full text

Medicine, Dermatology, Pediatrics +14